EO2002

BIOLOGICAL3 trials

Sponsors

Emmecell, Asociación para Evitar la Ceguera en México

Conditions

Bullous KeratopathyCataractCorneal EdemaCorneal Edema PseudophakicCorneal Endothelial DysfunctionCorneal Endothelial DystrophyEndothelial Cell Loss, CornealEndothelial Dysfunction

Phase 1

Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema

CompletedNCT04894110

EmmecellBullous Keratopathy, Corneal Edema, Corneal Endothelial Dysfunction +6

Start: 2021-06-22End: 2024-10-03Updated: 2025-03-05

Safety and Tolerability of EO2002

RecruitingNCT05587205

Asociación para Evitar la Ceguera en MéxicoCataract, Endothelial Cell Loss, Corneal

Start: 2022-08-30End: 2026-10-06Target: 32Updated: 2025-12-08

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

RecruitingNCT05636579

Asociación para Evitar la Ceguera en MéxicoBullous Keratopathy, Corneal Edema, Corneal Edema Pseudophakic +5

Start: 2022-11-08End: 2025-12-09Target: 12Updated: 2025-12-08